Subsequent studies have shown that CaMKKβ is a key effector of the androgen receptor in stimulating glycolysis through the activation of AMPK and phosphofructokinase (PFK), which drives anabolism and proliferation of prostate cancer cells [91]. This evidence concerns the gene AR and prostate cancer.